Literature DB >> 26357644

G-protein Coupled Estrogen Receptor (GPER/GPR30) and Women's Health.

Mi-Jin Kim1, Tae-Hee Kim2, Hae-Hyeog Lee2.   

Abstract

Estrogen - the female sexual hormone playing the most important role - plays a physiologically significant role, not only regulating in cell signals with second messenger but also being active in regulating transcription. Estrogen receptor (ER) which is a protein accepting estrogen not only play the role of a transcription factor combining with other genes to regulate their activity like other nuclear receptors but also performs external activities, combining with DNA, etc. G-protein coupled ER (GPER) that has been recently discovered exists as 7-membrane and has non-genomic (rapid) signaling. These functions, however, are not extensively addressed. This paper discusses the roles of GPER and its physiological mechanism.

Entities:  

Keywords:  Estradiol; Estrogens; GTP-binding proteins; Genomics

Year:  2015        PMID: 26357644      PMCID: PMC4561744          DOI: 10.6118/jmm.2015.21.2.79

Source DB:  PubMed          Journal:  J Menopausal Med        ISSN: 2288-6478


Introduction

The primary function of estrogen which is a steroid hormone playing the most important role in men and women is to develop the secondary sexual characters of woman and establish/maintain reproductive functions. The roles of 17β-estradiol in reproductive system control uterine and mammary growth and function. Also, 17β-estradiol has varied effects on the brain, including reduction of neuronal loss following stroke, increase in neuronal connectivity as well as on many diseases and cancers. This hormone becomes active largely when it combines with estrogen receptor (ER) that remains non-active in cells. Existing estrogens trigger reaction by combining with nuclear ERs - ER-alpha (ER-α) and ER-beta (ER-β). On the other hand, G-protein coupled ER (GPER) began to be known in recent years as a function of membrane receptors involved in the non-genomic mechanism of estrogen. In addition, subsequent studies found out that GPER is an important receptor mediating the activation of estrogen in immune system, nervous system, kidney system, vascular system, and reproductive system.1 Accordingly, this paper examines key reactions that affect the action mechanisms of existing ERs - ER-α and ER-β - and GPER that has been recently known in reference to the findings that have been made to date.

ER and GPER

Although most ERs that are having strong affinity with estrogen are ligand-dependent transcription factors in target tissue are known to mediate the action of estrogen, recent genetic, biological, and pharmacological studies of the signal transfer path of estrogen have shed light on several processes that directly influence ER functions, indicating the complexity of the action of estrogen.2 The first described ER-α is expressed in ovary, uterus, and mammary gland and located in chromosome 6, whereas ER-β is expressed in the ovary of female and the reproductive system of male and located in chromosome 14. Therefore, these two ERs are manifested in different places or in a different manner. This different may result from the very low amino acid homology of A/B domain of N-terminus and E/F domain of C-terminus that are known to have transaction activation function. On the other hand, GPER which is a transmembrane receptor engaging in the non-genomic mechanism of estrogen unlike ERs known to date via what is called non-genomic signal-genetic path was discovered by Owman3 in 1996, and referred to as GPR30 at first.4 Membrane-dependent genomic signal is the most distinctive estrogen signal mechanism containing estradiol combined with ER-α and ER-β.5 Although it is not known well yet, it has a rapid pathway containing G-protein. In addition, GPER transfers signal through GS protein, raises cyclic adenosine monophosphate (CAMP) production, increases epidermal growth factor receptor (EGFR) by raising epidermal growth factor, moves calcium within cells, activates extracellular signal-regulated kinase (ERK)1/2 and Src.67 However, GPER reportedly has the characteristics of ER that has single, high-affinitive, low-capacity estrogen linker module.8910

GPER and Ligand

In a recent report it is known that some specific GPER can be activated in different aspects by specific ligands for each receptor. ER antagonist and selective ER modulator such as tamoxifen show the importance of active as GPER agonist.11 In particular, as the selective agonist called G-1 is represented as selective GPER ligand12 and there is a study suggesting in regard to the biological significance of GPER that G-1 stimulates the growth of endometrium, breast, vagina, and testicular cancer cell in organs including organs and tissues including cancer tissues. Some recent studies say that non-steroid GPER agonist is the action factor of GPER functions and it will be used ofr subsequent studies.

GPER-Mediated Signaling

Signaling capability of GPER can have significant effect on conventional ERs in estrogen reactions. The role of GPR30 in the cell is based on the association of estrogen - mediated signal.1314 GPER has signal molecules having big structure in human genome15 and GPER-dependent synthesis mediated to the estrogen of mitogen-activated protein (MAP) kinase ERK1/2 through stimulation of EGFR transcription was studied for the first time. Inter-cell transfer of calcium and activation of P13K are known to be signal pathways and, as a result, it is known that GPER stimulates EGFR transcription11 and estrogen mediates the complex and prompt activation of cells in many aspects.

Future Direction

GPER that has been newly discovered is an ER playing many physiologically significant roles in human body. GPER is now being studies in relation to cancer and, in particular, cancers relating to such female reproductive organs as breast, uterus, ovary, etc. where GPER exists are being studies. In addition, physiological and pathophysiologic effects of GPER are expected to play a significant role in nervous system, kidney, and blood vessel tissues. However, as the activation mechanism of receptor and the roles of active substances are not systematically identified, these need to be studied to ensure extensive understanding of them. In conclusion, as the roles and actions of assistive active substances for activating GPER are not completely understood, effects of ligand synthesized by certain GPER need to be studied in the future to pave way for more systematic study of the complex action mechanism and functions of GPER.
  15 in total

Review 1.  Connections and regulation of the human estrogen receptor.

Authors:  Donald P McDonnell; John D Norris
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

Review 2.  Estrogen receptors: how do they signal and what are their targets.

Authors:  Nina Heldring; Ashley Pike; Sandra Andersson; Jason Matthews; Guojun Cheng; Johan Hartman; Michel Tujague; Anders Ström; Eckardt Treuter; Margaret Warner; Jan-Ake Gustafsson
Journal:  Physiol Rev       Date:  2007-07       Impact factor: 37.312

3.  Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors.

Authors:  Zeynep Madak-Erdogan; Karen J Kieser; Sung Hoon Kim; Barry Komm; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  2008-07-10

4.  Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt's lymphoma and widely distributed in brain and peripheral tissues.

Authors:  C Owman; P Blay; C Nilsson; S J Lolait
Journal:  Biochem Biophys Res Commun       Date:  1996-11-12       Impact factor: 3.575

5.  Nature of functional estrogen receptors at the plasma membrane.

Authors:  Ali Pedram; Mahnaz Razandi; Ellis R Levin
Journal:  Mol Endocrinol       Date:  2006-04-27

6.  Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.

Authors:  E J Filardo; J A Quinn; K I Bland; A R Frackelton
Journal:  Mol Endocrinol       Date:  2000-10

Review 7.  The G-protein-coupled estrogen receptor GPER in health and disease.

Authors:  Eric R Prossnitz; Matthias Barton
Journal:  Nat Rev Endocrinol       Date:  2011-08-16       Impact factor: 43.330

8.  G protein-coupled receptor 30 down-regulates cofactor expression and interferes with the transcriptional activity of glucocorticoid.

Authors:  Timo Ylikomi; Annika Vienonen; Tytti M Ahola
Journal:  Eur J Biochem       Date:  2004-11

9.  17beta-estradiol stimulates the growth of human keratinocytes by inducing cyclin D2 expression.

Authors:  Naoko Kanda; Shinichi Watanabe
Journal:  J Invest Dermatol       Date:  2004-08       Impact factor: 8.551

10.  Virtual and biomolecular screening converge on a selective agonist for GPR30.

Authors:  Cristian G Bologa; Chetana M Revankar; Susan M Young; Bruce S Edwards; Jeffrey B Arterburn; Alexander S Kiselyov; Matthew A Parker; Sergey E Tkachenko; Nikolay P Savchuck; Larry A Sklar; Tudor I Oprea; Eric R Prossnitz
Journal:  Nat Chem Biol       Date:  2006-03-05       Impact factor: 15.040

View more
  7 in total

1.  Mechanism Underlying the Effects of Estrogen Deficiency on Otoconia.

Authors:  Liping Yang; Yinfang Xu; Yan Zhang; Sarath Vijayakumar; Sherri M Jones; Yunxia Yesha Wang Lundberg
Journal:  J Assoc Res Otolaryngol       Date:  2018-04-23

2.  Impact of Environmentally Relevant Concentrations of Bisphenol A (BPA) on the Gene Expression Profile in an In Vitro Model of the Normal Human Ovary.

Authors:  Aeman Zahra; Rachel Kerslake; Ioannis Kyrou; Harpal S Randeva; Cristina Sisu; Emmanouil Karteris
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

3.  The Importance of G-protein Coupled Estrogen Receptor in Patients With Fibromyalgia.

Authors:  Tuba Koca; Burhan Koçyiğit; Muhammet Seyithanoğlu; Ejder Berk
Journal:  Arch Rheumatol       Date:  2019-01-23       Impact factor: 1.472

Review 4.  Flibanserin for Treating Hypoactive Sexual Desire Disorder.

Authors:  Jae Hong Sang; Tae-Hee Kim; Soo Ah Kim
Journal:  J Menopausal Med       Date:  2016-04-26

5.  Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer.

Authors:  Aeman Zahra; Qiduo Dong; Marcia Hall; Jeyarooban Jeyaneethi; Elisabete Silva; Emmanouil Karteris; Cristina Sisu
Journal:  J Clin Med       Date:  2021-05-05       Impact factor: 4.241

6.  Increased Serum G Protein-coupled Estrogen Receptor 1 Levels and Its Diagnostic Value in Drug Naïve Patients with Major Depressive Disorder.

Authors:  Ebru Findikli; Ergül Belge Kurutas; Mehmet Akif Camkurt; Mehmet Fatih Karaaslan; Filiz Izci; Hüseyin Avni Fındıklı; Selçuk Kardaş; Berat Dag; Hatice Altun
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-11-30       Impact factor: 2.582

7.  The absence of oestrogen receptor beta disturbs collagen I type deposition during Achilles tendon healing by regulating the IRF5-CCL3 axis.

Authors:  Xuting Bian; Tianyao Liu; Mingyu Yang; Chengyi Gu; Gang He; Mei Zhou; Hong Tang; Kang Lu; Fan Lai; Feng Wang; Qiandong Yang; Jan-Åke Gustafsson; Xiaotang Fan; Kanglai Tang
Journal:  J Cell Mol Med       Date:  2020-08-10       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.